v3.25.2
Stockholders' Equity (Deficiency) - Warrants Activity (Details) - USD ($)
3 Months Ended 6 Months Ended
Mar. 31, 2025
Jun. 30, 2025
Number of Warrants    
Outstanding at beginning balance 1,166,017 1,166,017
Issued   33,359,619
Repriced - Old   (197,118)
Repriced - New   197,118
Expired   (5,605)
Exercised   (449,118)
Outstanding at ending balance   34,070,913
Exercisable Number of warrants   1,061,294
Weighted Average Exercise Price    
Outstanding at beginning balance $ 22.33 $ 22.33
Issued   3.28
Repriced - Old   55.2
Repriced - New   5.27
Expired   207.39
Exercised   6.66
Outstanding at ending balance   3.28
Exercisable   $ 12.67
Weighted Average Remaining Life In Years, Outstanding   5 years
Weighted Average Remaining Life In Years, Exercisable   4 years 8 months 12 days
Aggregate Intrinsic Value, Outstanding   $ 237,986,992
Aggregate Intrinsic Value, Exercisable   $ 3,425,553
Warrants modification, Incremental costs $ 1,194,102  
Existing Warrants    
Weighted Average Exercise Price    
Number of warrants issued 197,118  
Exercise price $ 55.2  
Net proceeds from warrant exercises $ 900,000  
Payments for warrants issuance costs $ 116,456  
Existing Warrants | Reduction in Exercise Price of Warrants If Investor Immediately Exercised Warrants    
Weighted Average Exercise Price    
Exercise price $ 5.272  
Additional Warrants    
Weighted Average Exercise Price    
Number of warrants issued 394,236  
Exercise price $ 5.272  
Term of warrant 5 years